eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 01/12/2011
PIL Ziagen 20 mg/ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 10/11/2011 and displayed until 01/12/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 05/04/2011 and displayed until 10/11/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/09/2010 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/06/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 11/12/2009 and displayed until 24/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 19/06/2009 and displayed until 11/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 25/09/2008 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 17/06/2008 and displayed until 25/09/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to name of manufacturer
  • Change to Further Information section
Updated on 26/03/2007 and displayed until 17/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
Updated on 27/01/2005 and displayed until 26/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/07/2004 and displayed until 27/01/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 18/02/2004 and displayed until 08/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/05/2002 and displayed until 18/02/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   abacavir sulfate